ArticleEJHaem2022

Bortezomib-based therapy is effective and well tolerated in frontline and multiply pre-treated Waldenström macroglobulinaemia including BTKi failures: A real-world analysis.

Jahanzaib Khwaja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.